Iright
BRAND / VENDOR: Biolegend

Biolegend, 103112, APC anti-mouse CD45 Antibody, 100μg

CATALOG NUMBER: 103112
Regular price$0.99
/
Shipping calculated at checkout.
  • In stock, ready to ship

  • Backordered, shipping soon

This site is protected by hCaptcha and the hCaptcha Privacy Policy and Terms of Service apply.

Product Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.
100μg
Verified Reactivity: Mouse
Antibody Type: Monoclonal
Host Species: Rat
Immunogen: Mouse thymus or spleen
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation: The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration: 0.2 mg/ml
Storage & Handling: The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application: FC - Quality tested
Recommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.
Excitation Laser: Red Laser (633 nm)
Application Notes: Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45. Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).
Application References(PubMed link indicates BioLegend citation): Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC) Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP) Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC) Seaman WE. 1983. J. Immunol. 130:1713. (CMCD) Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC) Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed Liu F, et al. 2012. Blood. 119:3295. PubMed Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations: Gavin KM, et al. 2018. Front Endocrinol (Lausanne). 9:276. PubMed Wang L, et al. 2018. Bone Res. 6:22. PubMed Cha JH et al. 2018. Molecular cell. 71(4):606-620 . PubMed Haimon Z et al. 2018. Nature immunology. 19(6):636-644 . PubMed Ying W, et al. 2019. Cell Metab. 29:457. PubMed Strickley JD, et al. 2019. Nature. 575:519. PubMed Bohrer AC, et al. 2022. Cell Rep. 40:111144. PubMed Yu L, et al. 2022. Cancer Sci. 113:3980. PubMed Kuo A, et al. 2022. Elife. 11:. PubMed Chen LC, et al. 2023. Immunology. 169:271. PubMed Wilson NG, et al. 2023. iScience. 26:105991. PubMed Peng YJ, et al. 2023. Development. 150:. PubMed Wang JX, et al. 2023. JCI Insight. 8:. PubMed Pioli KT, et al. 2023. iScience. 26:106223. PubMed Wu Y, et al. 2023. Nat Cancer. 4:382. PubMed Henn RE, et al. 2023. iScience. 26:106164. PubMed Barberio AE, et al. 2023. Bioeng Transl Med. 8:e10453. PubMed Kawai H, et al. 2023. JBMR Plus. 7:e10722. PubMed Tan X, et al. 2023. Adv Sci (Weinh). 10:e2206768. PubMed Palakurthi B, et al. 2023. Nat Commun. 14:2109. PubMed Yao H, et al. 2023. Front Immunol. 14:1147674. PubMed Hernandez VG, et al. 2023. Glia. 71:1960. PubMed Liu H, et al. 2023. Breast Cancer Res. 25:43. PubMed Petenkova A, et al. 2023. Nat Commun. 14:2761. PubMed Abdelwahab T, et al. 2023. iScience. 26:106698. PubMed Shao X, et al. 2023. Cell Discov. 9:44. PubMed Vereertbrugghen A, et al. 2023. J Neuroinflammation. 20:120. PubMed Kalgudde Gopal S, et al. 2023. Nat Commun. 14:3020. PubMed Li M, et al. 2023. BMC Cancer. 23:497. PubMed Jiang Z, et al. 2021. J Clin Invest. 131: . PubMed Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed Kuo PC, et al. 2021. Brain Commun. 3:fcab187. PubMed Nigam S, et al. 2020. Mol Imaging Biol. 22:685. PubMed Yang D, et al. 2022. Cell. 185:1905. PubMed Witherel CE, et al. 2021. Biomaterials. 269:120667. PubMed Kozuki S, et al. 2022. Genes Cells. 27:192. PubMed Cautivo KM, et al. 2022. Immunity. 55:254. PubMed Liang X, et al. 2022. Cancer Commun (Lond). 42:205. PubMed Lloyd-Lewis B, et al. 2022. Cell Rep. 38:110461. PubMed Yang Y, et al. 2022. FEBS J. 289:5279. PubMed MacLean AJ, et al. 2022. Immunity. 55:718. PubMed Yousefi M, et al. 2022. Cancer Res. 82:1589. PubMed Van Deren DA, et al. 2022. Development. 149: . PubMed Lee R, et al. 2022. Cancer Discov. 12:1702. PubMed Jiang W, et al. 2022. FASEB J. 36:e22294. PubMed Wang S, et al. 2022. Sci Adv. 8:eabn3883. PubMed Wu TJ, et al. 2022. Cell Mol Life Sci. 79:348. PubMed Malhi H, et al. 2022. Cell Rep Med. 3:100658. PubMed Campisi L, et al. 2022. Nature. 606:945. PubMed Ma Z, et al. 2022. Theranostics. 12:4965. PubMed Richards M, et al. 2022. Elife. 11: . PubMed Gao Y, et al. 2022. Cell Res. 32:1086. PubMed Ge Y, et al. 2022. iScience. 25:105437. PubMed Liang Y, et al. 2022. Theranostics. 12:7729. PubMed Cattaneo P, et al. 2022. Nat Commun. 13:7444. PubMed Wang H, et al. 2022. J Nanobiotechnology. 20:513. PubMed Kuo CS, et al. 2022. Elife. 11: . PubMed Ge Y, et al. 2022. STAR Protoc. 4:101936. PubMed Yu J, et al. 2022. Nat Commun. 13:7903. PubMed Urata S, et al. 2023. Microbiol Immunol. 67:105. PubMed Al-Saafeen BH, et al. 2023. Front Immunol. 13:1017780. PubMed Hu R, et al. 2023. Cell Death Discov. 9:50. PubMed Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed Dragan M, et al. 2022. J Invest Dermatol. 142:583. PubMed Wei J, et al. 2022. Cancer Prev Res (Phila). 15:285. PubMed Yang Z, et al. 2022. J Nucl Med. 63:1708. PubMed Xin DQ, et al. 2022. Neural Regen Res. 17:2238. PubMed Li DD, et al. 2022. Cell Host Microbe. 30:530. PubMed Tan L, et al. 2022. Aging Dis. 13:1562. PubMed Bouchareychas L, et al. 2021. iScience. 24(8):102847. PubMed Almada AE, et al. 2021. Cell Reports. 34(4):108656. PubMed Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed Garcia-Fabiani MB, et al. 2020. Methods Enzymol. 632:369. PubMed Jaiswal AK, et al. 2020. Immunobiology. 225:151956. PubMed Cayre S, et al. 2020. Development. 147:00:00. PubMed Díaz NM, et al. 2020. Invest Ophthalmol Vis Sci. 61:37:00. PubMed Mourao L, et al. 2019. Sci Rep. 0.991666667. PubMed Oetjen LK et al. 2017. Cell. 171(1):217-228 . PubMed Testini C, et al. 2019. EMBO Rep. 20:e47845. PubMed Gao Q, et al. 2019. J Exp Med. 216:688. PubMed Shavit Stein E, et al. 2018. Neural Plast. 2018:7692182. PubMed Ahmed M, et al. 2016. Development. 143: 1663 - 1673. PubMed Yu K, et al. 2021. Cell Reports. 35(12):109273. PubMed Lim JT, et al. 2020. Mol Cancer Ther. 1809:19. PubMed Karlen SJ, et al. 2018. J Neuroinflammation. 15:344. PubMed Du Q, et al. 2019. Front Microbiol. 10:2050. PubMed Kang I, et al. 2012. Blood. 119:3295. PubMed Rosa FF, et al. 2020. Bio Protoc. 10:e3619. PubMed Wang Y, et al. 2021. J Bone Oncol. 30:100386. PubMed Lu L, et al. 2022. Sci Rep. 12:931. PubMed Parhiz H, et al. 2022. J Control Release. 344:50. PubMed Yanagida K, et al. 2020. Dev Cell. 779:52. PubMed Hirano KI, et al. 2021. eLife. 0.416666666666667. PubMed Larouche JA, et al. 2021. eLife. 0.416666666666667. PubMed Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed Barberio AE, et al. 2020. ACS Nano. 14:11238. PubMed Chiche A, et al. 2016. Oncogene. 10.1038/onc.2016.396. PubMed Eastman A, et al. 2016. J Immunol . 194: 5999-6010. PubMed Engelbrecht E, et al. 2020. eLife. 9:e52690.. PubMed Hays C, et al. 2020. eLife. 8:e48772.. PubMed Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed Chen J, et al. 2022. Nat Commun. 13:6759. PubMed Wang S, et al. 2022. Front Immunol. 13:869061. PubMed Zhang Y, et al. 2022. Cancers (Basel). 14:. PubMed Barwe SP, et al. 2022. J Clin Med. 11:. PubMed Tilstam PV, et al. 2021. J Clin Invest. 131:. PubMed Yu X, et al. 2021. Nature. 594:560. PubMed Sato S, et al. 2021. Int J Mol Sci. 22:. PubMed Oliva Chávez AS, et al. 2021. Nat Commun. 12:3696. PubMed Strunz M, et al. 2020. Nat Commun. 2.929861111. PubMed Shemer A, et al. 2020. Immunity. 53(5):1033-1049.e7. PubMed Schiller M, et al. 2021. Immunity. 54(5):1022-1036.e8. PubMed Wosczyna MN, et al. 2021. Cell Stem Cell. 28(7):1323-1334.e8. PubMed Okuniewska M, et al. 2021. Cell Reports. 36(2):109368. PubMed Zhao B, et al. 2021. Cell Reports. 36(3):109401. PubMed Motoyama S, et al. 2020. Cells. :9. PubMed Jin X, et al. 2019. Mol Cell. 73:22:00. PubMed Duarte N, et al. 2018. Hepatol Commun. 0.833333333. PubMed Park JA, et al. 2021. J Hematol Oncol. 14:142. PubMed Romagnoli M, et al. 2020. Development. 147:. PubMed Li Q, et al. 2021. Brain Behav Immun. 94:437. PubMed Wang X, et al. 2022. Nat Aging. 2:155. PubMed Wang T, et al. 2020. Blood Sci. 2:79. PubMed Lv H, et al. 2020. Cell Metabolism. 33(1):110-127.e5. PubMed Amouyal C, et al. 2020. EBioMedicine. 58:102895. PubMed Liu L, et al. 2015. Neurol Neuroimmunol Neuroinflamm. 2: 174. PubMed Hyatt L, et al. 2014. PLoS One. 9:109072. PubMed Pelletier A, et al. 2012. J Immunol. 188:5561. PubMed Herting CJ, et al. 2019. Brain. 142:3834. PubMed Romagnoli M, et al. 2019. Stem Cell Reports. 1.077083333. PubMed Ning X, et al. 2019. Mol Cell. 74:19. PubMed De S, et al. 2018. Development. 145. PubMed Xiao X, et al. 2019. Cell Discov. 5:2. PubMed Mauduit O, et al. 2022. Front Immunol. 13:1011125. PubMed Chen Z, et al. 2022. Theranostics. 12:6242. PubMed Xu X, et al. 2021. J Nanobiotechnology. 19:376. PubMed Bourn JR, et al. 2021. Cancer Lett. 503:75. PubMed Khateb M, et al. 2022. Cell Rep. 40:111219. PubMed Xu Q, et al. 2022. Proc Natl Acad Sci U S A. 119:. PubMed Liu K, et al. 2022. Theranostics. 12:639. PubMed Sato Y, et al. 2021. J Clin Invest. Online ahead of print. PubMed Lafkas D, et al. 2013. J Cell Biol. 203:47. PubMed Ma S, et al. 2021. Cell Reports. 34(6):108726. PubMed Ankawa R, et al. 2021. Developmental Cell. . PubMed An J,et al. 2017. Sci Rep.. 10.1038/s41598-017-13629-0. PubMed Wosczyna MN et al. 2019. Cell Rep. 27(7):2029-2035 . PubMed Maston LD, et al. 2017. Am J Physiol Lung Cell Mol Physiol. 312:L609. PubMed Bresson L, et al. 2018. Development. 145. PubMed Charmsaz S, et al. 2017. Leukemia. 31:1779. PubMed Sambasivan R, et al. 2011. Development. 138:3647. PubMed Hu EY, et al. 2021. Blood Adv. 5:3152. PubMed Palathingal Bava E, et al. 2022. JCI Insight. 7:. PubMed Shcherbina A, et al. 2020. Cell Rep. 32:107964. PubMed Wu J, et al. 2020. Immunity. 53:115. PubMed Frii J, et al. 2021. Immunity. 54(5):1002-1021.e10. PubMed Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed Kotfis K, et al. 2020. British Journal of Pharmacology. 49(1):66-72. PubMed Xiao P, et al. 2019. J Exp Med. 216:337. PubMed Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed Zheng B, et al. 2018. J Hematol Oncol. 11:16. PubMed Pal B, et al. 2017. Nat Commun.. 10.1038/s41467-017-01560-x. PubMed Fischer A, et al. 2022. Nat Immunol. 23:518. PubMed Hu J, et al. 2022. Cell Mol Neurobiol. . PubMed Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed Yuan Z, et al. 2018. Emerg Microbes Infect. 7:59. PubMed Hou M, et al. 2020. Stem Cell Res Ther. 11:55. PubMed Morimoto A, et al. 2021. Nat Commun. 12:2136. PubMed Hanasoge Somasundara AV, et al. 2021. Cell Rep. 37:110099. PubMed Thinard R, et al. 2022. Pharmaceutics. 14:. PubMed Yang H, et al. 2022. Nutrients. 14:. PubMed Hu J, et al. 2022. J Neuroinflammation. 19:71. PubMed Pezoldt J, et al. 2022. Nat Commun. 13:7227. PubMed Jia Q, et al. 2021. Theranostics. 4699:11. PubMed Paiva-Oliveira E, et al. 2017. Histochem Cell Biol. 10.1007/s00418-017-1556-6. PubMed Dudek KA, et al. 2020. Proc Natl Acad Sci U S A. 117:3326. PubMed Bradley KC, et al. 2019. Cell Rep. 28:245. PubMed Crooks SD, et al. 2022. Immunohorizons. 6:705. PubMed Yang J, et al. 2022. Microbiome. 10:149. PubMed Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed Koren E, et al. 2022. Nat Commun. 13:4628. PubMed Bauer T, et al. 2021. Life (Basel). 11:. PubMed Li P, et al. 2022. EMBO Mol Med. 14:e14511. PubMed Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed Myerson JW, et al. 2021. Nat Nanotechnol. Online ahead of print. PubMed Wang C, et al. 2011. Hepatology. 55:108. PubMed Sim S, et al. 2016. PLoS One. 11: 0152485. PubMed Mangum L, et al. 2016. Toxicol Sci. 150: 169 - 177. PubMed Mizuno T, et al. 2017. Sci Rep. 7:42714. PubMed Nosho S, et al. 2020. Int J Mol Sci. 21:00. PubMed Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed Kaur A, et al. 2019. Cancer Discov. 9:64. PubMed Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed Zhou G, et al. 2019. FASEB J. 33:11396. PubMed Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed Yang Y, et al. 2022. Elife. 11:. PubMed Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed Zhang Q, et al. 2022. Nat Commun. 13:2406. PubMed Scur M, et al. 2022. Nat Commun. 13:7272. PubMed Xi W, et al. 2021. Stem Cell Res Ther. 167:12. PubMed Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed Dawson CA, et al. 2021. Nature Protocols. 16(4):1907-1935. PubMed Seki T, et al. 2015. J Biochem. 158: 485 - 495. PubMed Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed Tu WL, et al. 2018. Am J Pathol. 188:2688. PubMed Chiche A, et al. 2019. Breast Cancer Res. 21:13. PubMed Feng J,et al. 2017. Nat Commun. . 10.1038/s41467-017-01056-8. PubMed Limbad C, et al. 2022. iScience. 25:103848. PubMed Chiang HY, et al. 2022. Nat Commun. 13:874. PubMed Aguilera M, et al. 2021. Int J Mol Sci. 22:. PubMed Garcia-Bonilla L, et al. 2014. J Immunol. 193:2531. PubMed Ding X, et al. 2015. J Immunol. 194:4251. PubMed Wang L, et al. 2015. Cancer Immunol Res. 3: 1030-1041. PubMed Mueller A, et al. 2016. Nature. 540:276-279. PubMed Perry JL, et al. 2020. ACS Nano. 5.583333333. PubMed Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed Penkert RR, et al. 2020. Obesity (Silver Spring). 1631:28. PubMed Mori A, et al. 2021. Cells. :10. PubMed Echevarría-Vargas IM, et al. 2018. EMBO Mol Med. 10:e8446. PubMed Shi R, et al. 2019. J Cancer. 10:367. PubMed Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed Usmani SM et al. 2019. Cell host & microbe. 25(1):73-86 . PubMed Zas&lstrok;ona Z, et al. 2017. Am J Physiol Lung Cell Mol Physiol. 312:L855. PubMed Nowlan B, et al. 2019. Haematologica. 105:71. PubMed Liu D, et al. 2020. Front Pharmacol. 11:204. PubMed Dion-Albert L, et al. 2022. Nat Commun. 13:164. PubMed Long JT, et al. 2022. Elife. 11:. PubMed Zhang Z, et al. 2021. Exp Dermatol. 30:102. PubMed Han Y, et al. 2022. Int J Biol Sci. 18:5653. PubMed Yang Y, et al. 2021. Cell Reports. 34(10):108822. PubMed Taya M, et al. 2020. Endocr Relat Cancer. 27:261. PubMed Cai B, et al. 2020. Cell Metabolism. 31(2):406-421.e7.. PubMed Lu Y, et al. 2020. Immunity. 52:782. PubMed Toyama K, et al. 2018. Arterioscler Thromb Vasc Biol. 38:1392. PubMed Qiao S, et al. 2019. J Neuroinflammation. 16:4. PubMed Saber M, et al. 2021. J Neurosci Res. 99:1136. PubMed Takaku S, et al. 2022. Evid Based Complement Alternat Med. 2022:6122955. PubMed Murdock BJ, et al. 2021. JCI Insight. 6:. PubMed Elias S, et al. 2015. PLoS Biol. 13:1002142. PubMed Deng P, et al. 2021. Cell Stem Cell. 28(6):1057-1073.e7. PubMed Zhang Y, et al. 2020. Cancer Res. 80:3345. PubMed Carmody C et al. 2019. Endocrinology. 160(5):1205-1222 . PubMed Fu NY, et al. 2018. Dev Cell. 47:629. PubMed Yousef H, et al. 2019. Nat Med. 25:988. PubMed Yeo SK, et al. 2020. eLife. 9:e58810.. PubMed Zhang J, et al. 2022. Biomater Res. 26:44. PubMed Hoover AR, et al. 2022. Clin Transl Med. 12:e937. PubMed Bagati A, et al. 2020. Cancer Cell. 39(1):54-67.e9. PubMed Nasser H, et al. 2020. Cell Death Discov. 0.29375. PubMed Sroor HM, et al. 2019. Sci Rep. 9:20217. PubMed Chen PY, et al. 2019. Nat Metab. 0.675. PubMed Cao Y, et al. 2019. Nat Commun. 10:1280. PubMed Liu L et al. 2018. Cell stem cell. 23(4):544-556 . PubMed Zheng Y, et al. 2022. J Immunol. 208:501. PubMed Zhang T, et al. 2020. JCI Insight. 5:00. PubMed Porrello A, et al. 2018. Nat Commun. 9:1988. PubMed Cai T, et al. 2022. Nat Commun. 13:2228. PubMed Kim KS, et al. 2022. JCI Insight. 7:. PubMed Saber M, et al. 2020. Eur J Neurosci. 52:2791. PubMed Vaas M, et al. 2016. J Cereb Blood Flow Metab. 10.1177/0271678X16676825. PubMed Wong J, et al. 2016. Sci Signal. 9: ra103. PubMed Yuan Z, et al. 2016. J Virol. 90: 7728 - 7739. PubMed Garcia-Bonilla L, et al. 2015. J Neurosci. 35: 14783 - 14793. PubMed Jiang Y, et al. 2015. MBio. 6: e01426-15. PubMed Roberts L, et al. 2014. Infect Immun . 82:2504. PubMed Ortiz A, et al. 2019. Cancer Cell. 35:33:00. PubMed Ouadah Y, et al. 2019. Cell. 179:403. PubMed Piotrowski AF, et al. 2018. Oncoimmunology. 7:e1445951. PubMed Sarshad AA, et al. 2018. Mol Cell. 71:1040. PubMed Gopalakrishnapillai A, et al. 2021. Cancers (Basel). 13:. PubMed Liu G, et al. 2022. Theranostics. 12:2248. PubMed Piirainen S, et al. 2021. Glia. 69:2459. PubMed Arora S, et al. 2021. Med (N Y). 2:938. PubMed Li H, et al. 2022. iScience. 25:104481. PubMed Cayre S, et al. 2020. Development. . PubMed Endo-Umeda K, et al. 2021. Sci Rep. 11:22595. PubMed Pal B, et al. 2021. Breast Cancer Res. 23:69. PubMed Maller O, et al. 2020. Nat Mater. 20:548. PubMed Jaeger N, et al. 2020. Cell Rep. 33:108331. PubMed Koh BI, et al. 2020. Nat Commun. 3.143055556. PubMed Ren D, et al. 2020. Am J Cancer Res. 2851:10. PubMed Su M, et al. 2018. Immunol Cell Biol. 9:2448. PubMed Wunderlich CM, et al. 2018. Nat Commun. 9:1646. PubMed Peltzer N, et al. 2018. Nature. 557:112. PubMed Qu Y, et al. 2020. Cell Reports. 32(1):107873. PubMed Hu Y, et al. 2021. J Nanobiotechnology. 19:416. PubMed Kastenschmidt JM, et al. 2021. Cell Rep. 35:108997. PubMed Dai B, et al. 2021. Cell Reports Medicine. 2(8):100381. PubMed Bravo JI, et al. 2021. STAR Protocols. 2(2):100406. PubMed Chng S, et al. 2016. Sci Rep. 6: 23820. PubMed Kabir AU, et al. 2018. JCI Insight. 3. PubMed Quijano-Rubio A, et al. 2022. Nat Biotechnol. Online ahead of print. PubMed Scheyltjens I, et al. 2022. Nat Protoc. 17:2354. PubMed Liu C, et al. 2022. Nat Commun. 13:1989. PubMed Saber M, et al. 2021. J Neurotrauma. 38:2862. PubMed Wang Y, et al. 2022. Nat Cell Biol. 24:230. PubMed Okubo A, et al. 2021. Int J Mol Sci. 23:. PubMed Deets KA, et al. 2021. Elife. 10:. PubMed Murray CW, et al. 2022. Nat Commun. 13:1090. PubMed Song X, et al. 2022. Transl Oncol. 15:101306. PubMed Zhong J, et al. 2021. Commun Biol. 4:865. PubMed Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
RRID: AB_312976 (BioLegend Cat. No. 103111) AB_312977 (BioLegend Cat. No. 103112)
Structure: Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution: All hematopoietic cells except mature erythrocytes and platelets
Function: Phosphatase, T and B cell activation
Ligand/Receptor: Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type: B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area: Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family: CD Molecules
Antigen References: 1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press. 2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85. 3. Kishihara K, et al. 1993. Cell 74:143. 4. Pulido R, et al. 1988. J. Immunol. 140:3851.
Gene ID: 19264
UniProt: View information about CD45 on UniProt.org
Clone: 30-F11
Regulatory Status: RUO
Other Names: T200, Ly-5, LCA
Isotype: Rat IgG2b, κ


Order Guidelines

1. Price & Stock Available on Request. 📧Click to send email to: service@iright.com

2. Please DO NOT make payment before confirmation.

3. Minimum order value of $1,000 USD required.

Collaboration

Tony Tang

📧Email: Tony.Tang@iright.com

📱Mobile/WhatsApp/Wechat: +86-17717886924